Have you signed up yet? There's still time, and you get a 50% discount as a DANISH BIO member 🎇 https://lnkd.in/gj8-pf6
DANISH BIO - DANSK BIOTEK
Bioteknologi
working to promote innovation, research and development in life science in Denmark
Om os
DANSK BIOTEK is an active trade organisation which is in a continuous dialogue with the Danish authorities and who is recognised as an authority regarding biotechnology in the public debate. DANSK BIOTEK has furthermore taken steps to increase the public knowledge about modern biotechnology. The organisation publishes articles, participates in political meetings and in the public debate and teaches in biotech research conditions, genetic modification, ethical matters, etc. DANSK BIOTEK has an influence on decisions regarding state funds for innovative research and entrepreneurial activities and has contributed to the wording of rules and regulations regarding biotechnological patenting, research and production in Denmark and Europe. We also participate actively in biotech analyses as for instance the Analysis regarding Conditions for the Danish Capital. Furthermore, DANSK BIOTEK is collaborating with The Danish Association of the Pharmaceutical Industry (LIF) about clinical research in Denmark.
- Websted
-
http://www.danskbiotek.dk
Eksternt link til DANISH BIO - DANSK BIOTEK
- Branche
- Bioteknologi
- Virksomhedsstørrelse
- 1 medarbejder
- Hovedkvarter
- Copenhagen N
- Type
- Nonprofit
Beliggenheder
-
Primær
COBIS, Ole Maaløes Vej 3
Copenhagen N, 2200, DK
Medarbejdere hos DANISH BIO - DANSK BIOTEK
Opdateringer
-
See the results of the clinical trials analysis by Lif - Lægemiddelindustriforeningen.
Hvordan går det egentlig med klinisk forskning i Danmark? 🔬 En ny analyse fra Lif og DANISH BIO - DANSK BIOTEK er udkommet, og der er masser af spændende indsigter at dykke ned i. Vi ser en stigning i både antallet af igangværende kliniske forsøg og beskæftigelsen inden for området. Danmark fortsætter med at være et attraktivt sted for forskning og udvikling. Men der er også en bekymring: Antallet af nye kliniske forsøg er faldende, og det kan få konsekvenser for medicinsk forskning på den lange bane. Derfor er det afgørende, at vi forstår årsagerne til det og arbejder på at vende udviklingen, siger Jakob Bjerg Larsen i artiklen. 📊 Læs mere her: https://lnkd.in/dUMsVGzt
-
DANISH BIO - DANSK BIOTEK genopslog dette
Don't miss out on this opportunity to hear the wise words of some of the most knowledgeable people wihtin this extremely fast developing area 🙌 Presenting Emma Jappe, Martin S. Borchert, Roald Forsberg, Nabiha Saklayen and in the beautiful facilities of Gorrissen Federspiel We can't wait to see you 🤗 Register here: https://lnkd.in/dfNSeAxR
🎇 PROGRAMME REVEAL 🎇 We got the final pieces together for our traditional ANNUAL MEETING, and are now ready to reveal the programme the event which will generously be hosted by our member firm, Gorrissen Federspiel Register now to save your seat! https://lnkd.in/dfNSeAxR
-
Don't miss out on this opportunity to hear the wise words of some of the most knowledgeable people wihtin this extremely fast developing area 🙌 Presenting Emma Jappe, Martin S. Borchert, Roald Forsberg, Nabiha Saklayen and in the beautiful facilities of Gorrissen Federspiel We can't wait to see you 🤗 Register here: https://lnkd.in/dfNSeAxR
🎇 PROGRAMME REVEAL 🎇 We got the final pieces together for our traditional ANNUAL MEETING, and are now ready to reveal the programme the event which will generously be hosted by our member firm, Gorrissen Federspiel Register now to save your seat! https://lnkd.in/dfNSeAxR
-
Amazing news from the Danish biotech world - and for patients with Niemann-Pick Disease, type C (NPC) in the US. The FDA has approved #arimoclomol #Miplyffa, which was developed by Thomas Kirkegaard Jensen and the team at #Orphazyme, and subsequently brought all the way to approval by Zevra Therapeutics led by their team in Copenhagen. Congratulations for this wonderful outcome after years of hard work and many frustrations! Louise Himmelstrup Christine i Dali Anders Mørkeberg Hinsby
-
📣 Have you registered for SUND Innovation Day 2024? If you haven't already, then you certainly should! "The event is a celebration of the innovative minds and entrepreneurial spirits of researchers at UCPH. We bring together researchers, staff members, experts from industry, ecosystem, and venture capital. The day will give a unique opportunity to learn from inspiring pioneers in translational and innovative research" Among speakers are: Christian Ørsted, Mette Trauelsen, John Haurum, Julie Gehl, Agnete Kirkeby Registration here: https://lnkd.in/epuebGUP
Innovation Day 2023
healthsciences.ku.dk
-
Yesterday, we had the pleasure of co-hosting a Biotech Salon with Ozack ApS who shared their very relevant expertise in submitting CTAs in the CTIS. Ivana and Ann Christine presented in a very easily understandable way the mysterious ways of the systems, so that everyone - even the DANISH BIO dispatch - were able to follow and learn. Thank you very much to our attending members as well as to Ozack ApS🙌
-
We're co-hosting this very relevant event tomorrow with Ozack ApS, and if you're being real quick, we can still squeeze in another seat or two. Wanna come?
Did you sign up yet for this extremely relevant event? There are still a few seats available ... You can sign up here: https://lnkd.in/dtcr96_i
-
Well done, Gubra 💯 Congratulations and thank you for putting in the effort!
We are truly pleased to share that Gubra has won a diploma for 'Best Annual Report among Small and Medium-sized Enterprises 2024' at today's Danish Annual Reporting Awards! The jury praised our report for its clear and "non-text heavy" presentation of our research and business model, strategic priorities, and commitment to ESG, including important preliminary steps towards CSRD reporting. The report, they say, "can serve as inspiration for others". This is exactly what we had hoped for. Thank you to the DI - Confederation of Danish Industry - Confédération des Industries Danoises for this recognition! In pictures below CFO of Gubra Kristian Borbos receiving the diploma on behalf of his team and Gubra. #Gubra #AnnualReport #DanishAwards #SMEs #ESG